首页|期刊导航|广州中医药大学学报|泽泻丹明饮治疗高脂血症合并非酒精性脂肪肝痰湿证的临床研究

泽泻丹明饮治疗高脂血症合并非酒精性脂肪肝痰湿证的临床研究OA

Clinical Study on Zexie Danming Yin in Treating Hyperlipidemia Complicated with Nonalcoholic Fatty Liver Disease of Phlegm-Damp Type

中文摘要英文摘要

[目的]探讨泽泻丹明饮治疗高脂血症合并非酒精性脂肪肝(NAFLD)痰湿证患者的临床疗效及安全性.[方法]选取2022年6月至2024年8月在新疆维吾尔自治区中医医院就诊的120例高脂血症合并NAFLD痰湿证患者为研究对象,采用随机数字表法将患者随机分为对照组和治疗组,每组各60例.对照组患者采用生活方式干预,观察组患者采用生活方式干预+泽泻丹明饮治疗,疗程为24周.观察2组患者治疗前后脂代谢指标[总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]、基于瞬时弹性成像技术的肝脏指标[受控衰减参数(CAP)、肝脏硬度值(LSM)]、体质量指数(BMI)的变化情况,比较2组患者的中医证候疗效、血脂改善疗效和肝脏瞬时弹性疗效;并对2组患者的用药安全性进行评估.[结果](1)剔除、脱落情况方面,治疗组剔除、脱落3例,对照组剔除、脱落2例;最终,治疗组纳入57例,对照组纳入58例.(2)疗效方面,治疗24周后,治疗组的中医证候疗效、血脂改善疗效和肝脏瞬时弹性疗效的总有效率分别为70.18%(40/57)、70.18%(40/57)、59.65%(34/57),对照组分别为50.00%(29/58)、55.17%(32/58)、44.83%(26/58),组间比较(χ2检验),治疗组的中医证候疗效明显优于对照组(P<0.05),而血脂改善疗效和肝脏瞬时弹性疗效有优于对照组趋势,但差异均无统计学意义(P>0.05).(3)脂代谢指标方面,治疗后,治疗组的TC、LDL-C、TG水平均较治疗前明显下降(P<0.05或P<0.001),HDL-C水平治疗前后无明显差异(P>0.05);对照组治疗前后的TC、LDL-C、TG、HDL-C水平均无明显变化(P>0.05);治疗组对TC、LDL-C水平的降低幅度均明显优于对照组,组间治疗前后差值比较,差异均有统计学意义(P<0.01).(4)基于瞬时弹性成像技术的肝脏指标方面,治疗后,2组患者的CAP和LSM值均较治疗前明显降低(P<0.05或P<0.001),且治疗组对CAP和LSM值的降低幅度均明显优于对照组,组间治疗前后差值比较,差异均有统计学意义(P<0.05).(5)BMI方面,治疗后,2组患者的BMI值均较治疗前改善(P<0.05或P<0.001),且治疗组对BMI值的改善幅度明显优于对照组,组间治疗前后差值比较,差异有统计学意义(P<0.01).(6)安全性方面,除治疗组的尿素水平外,2组患者治疗前后的肌酐、尿素、谷丙转氨酶、谷草转氨酶等肝、肾功能指标比较,差异均无统计学意义(P>0.05).[结论]在常规生活方式干预的基础上应用泽泻丹明饮治疗高脂血症合并NAFLD痰湿证患者疗效确切,能有效改善患者的脂肪肝和血脂水平,且具有较高的安全性.

Objective To investigate the clinical efficacy and safety of Zexie Danming Yin(a dispensing granule mainly composed of Alismatis Rhizoma,Salviae Miltiorrhizae Radix et Rhizoma,Cassiae Semen,Curcumae Radix,Crataegi Fructus,etc.)in treating patients with hyperlipidemia complicated with nonalcoholic fatty liver disease(NAFLD)of phlegm-damp type.Methods A total of 120 patients with hyperlipidemia complicated with NAFLD of phlegm-damp type,who visited the Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital from June 2022 to August 2024 were enrolled as study subjects.The patients were randomly divided into control group and treatment group by random number table method,with 60 cases in each group.The control group received lifestyle intervention,while the observation group received lifestyle intervention combined with oral use of Zexie Danming Yin.The treatment duration was 24 weeks.The changes in lipid metabolism indicators[total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),and high-density lipoprotein cholesterol(HDL-C)],liver parameters based on transient elastography[controlled attenuation parameter(CAP),and liver stiffness measurement(LSM)],and body mass index(BMI)were observed before and after treatment in both groups.The therapeutic effects on traditional Chinese medicine(TCM)syndrome,lipid improvement,and liver transient elastography were compared between the two groups,and the medication safety was evaluated.Results(1)Regarding exclusions and dropouts,3 cases in the treatment group and 2 cases in the control group were excluded or dropped out.Finally,57 cases were included in the treatment group and 58 cases in the control group.(2)In terms of efficacy,after 24 weeks of treatment,the total effective rates of TCM syndrome efficacy,lipid improvement efficacy,and liver transient elastography efficacy in the treatment group were 70.18%(40/57),70.18%(40/57),and 59.65%(34/57),respectively,while those in the control group were 50.00%(29/58),55.17%(32/58),and 44.83%(26/58),respectively.Inter-group comparison(by chi-square test)showed that the TCM syndrome efficacy in the treatment group was significantly superior to that in the control group(P<0.05),while the lipid improvement efficacy and liver transient elastography efficacy showed a trend of being superior to the control group,but the differences were not statistically significant(P>0.05).(3)Regarding lipid metabolism indicators,after treatment,the levels of TC,LDL-C,and TG in the treatment group were significantly decreased compared with those before treatment(P<0.05 or P<0.001),while the HDL-C level showed no significant difference before and after treatment(P>0.05).In the control group,there were no significant changes in TC,LDL-C,TG,or HDL-C levels after treatment compared with those before treatment(P>0.05).The reductions in TC and LDL-C levels in the treatment group were significantly greater than those in the control group,and the differences in the pre-and post-treatment changes between the groups were statistically significant(P<0.01).(4)Regarding liver parameters based on transient elastography,after treatment,the CAP and LSM values in both groups were significantly decreased compared with those before treatment(P<0.05 or P<0.001),and the reductions in CAP and LSM values in the treatment group were significantly greater than those in the control group,with statistically significant differences in the pre-and post-treatment changes between the groups(P<0.05).(5)Regarding BMI,after treatment,the BMI values in both groups were improved compared with those before treatment(P<0.05 or P<0.001),and the improvement in BMI in the treatment group was significantly greater than that in the control group,with a statistically significant difference in the pre-and post-treatment changes between the groups(P<0.01).(6)Regarding safety,except for the urea level in the treatment group,there were no statistically significant differences in liver and kidney function indicators such as creatinine,urea,alanine aminotransferase,and aspartate aminotransferase between the two groups before and after treatment(P>0.05).Conclusion The application of Zexie Danming Yin on the basis of conventional lifestyle intervention has a definite therapeutic effect in treating patients with hyperlipidemia complicated with NAFLD of phlegm-damp type.It can effectively improve fatty liver and blood lipid levels,and has high safety.

陈苗苗;贾佳;孙敬雯;洪军

新疆维吾尔自治区中医医院,新疆 乌鲁木齐 830000新疆维吾尔自治区中医医院,新疆 乌鲁木齐 830000新疆维吾尔自治区中医医院,新疆 乌鲁木齐 830000新疆维吾尔自治区中医医院,新疆 乌鲁木齐 830000

医药卫生

高脂血症非酒精性脂肪肝痰湿证泽泻丹明饮临床疗效安全性

hyperlipidemianonalcoholic fatty liver diseasephlegm-damp syndromeZexie Danming Yinclinical efficacysafety

《广州中医药大学学报》 2026 (6)

1473-1480,8

新疆维吾尔自治区自然科学基金青年科学基金资助项目(编号:2024D01C293)新疆医科大学附属中医医院院内科研课题(编号:ZYY202101)

10.13359/j.cnki.gzxbtcm.2026.06.007

评论